FEATURES OF THE COURSE OF PREGNANCY, CHILDBIRTH AND POSTPARTUM PERIOD IN PATIENTS WITH ADENOMYOSIS
https://doi.org/10.21886/2219-8075-2020-11-1-41-45
Abstract
Objective: to assess the course of pregnancy, childbirth and postpartum period in patients with adenomyosis 1 and 2 degrees.
Materials and methods: the course of pregnancy and its outcomes were analyzed in 153 primordial women with a history of adenomyosis of 1–2 degrees (I group), the control group (II group) — 150 conditionally healthy primordial women.
Results: in preterm patients with adenomyosis of 1 and 2 degrees, in the absence of problems with conception and somatic pathology, statistically significantly increases the number of early reproductive losses and premature birth during pregnancy statistically significantly more often formed placental insufficiency and increases the frequency of hypertension disorders, increases the frequency of pathology of labor and postpartum period, mainly associated with increased blood loss.
Conclusion: complications of gestation, pathology of labor and postpartum period in patients even with 1 stage of adenomyosis are largely associated with histological, immunohistochemical and immunological features of the structure of the transition zone «endometrium-myometrium». Pathological processes occurring in the zone of remodeling of spiral arterioles may lead to abnormal chorion formation, which causes most obstetric complications.
About the Authors
E. I. Kravtsova
Kuban State Medical University
Russian Federation
Russian Federation
Elena I. Kravtsova — Cand. Sci. (Med.), Associate Professor of obstetrics, gynecology and Perinatology department.
Krasnodar
I. I. Kutsenko
Kuban State Medical University
Russian Federation
Competing Interests:
Russian Federation
Competing Interests:
Irina I. Kutsenko — Dr. Sci. (Med.), Prof., head of the Department of obstetrics, gynecology and Perinatology.
Krasnodar
A. A. Avakimyan
Kuban State Medical University
Russian Federation
Russian Federation
Artem A. Avakimyan — Cand. Sci. (Med.), assistant of the Department of obstetrics, gynecology and Perinatology.
Krasnodar
References
1. Adamyan L.V., Andreeva E.N., Apolikhina I.A., Bezhenar V.F., et al. Endometriosis: diagnosis, treatment and rehabilitation. Federal clinical guidelines for the management of patients. Moscow: Russian society of obstetricians and gynecologists; 2013. (in Russ.)
2. Zayratyants O.V., Andreeva E.N., Adamyan L.V., Sonova M.M., Urumova L.T., et al. Endometriosis: a new experience of nonhormonal drug therapy. Reproduction problems. 2018;24(6):113-120. (in Russ.) https://doi.org/10.17116/repro201824061113
3. Kutsenko I.I., Kravtsova E.I., Simovonik A.N., Rudeeva O.A. Ultrasound diagnostics of adenomyosis of i degrees of distribution. Modern problems of science and education. 2017;6:138. (in Russ.) eLIBRARY ID: 32390430
4. Tapilskaya N.I., Gaidukov S.N., Shanina T.B. Adenomyosis as an independent phenotype of endomyometrial dysfunction. Effective pharmacotherapy. 2015;1(5):62-68. (in Russ.) eLIBRARY ID: 23109304
5. Unanyan A.L., Sidorova I.S., Kogan E.A., Belogubova S.Yu., Demura T.A., et al. Endometriosis, adenomyosis, chronic endometritis: clinical and pathogenetic relationships and reproductive failures. Obstetrics and gynecology. 2018;10:136-40. (in Russ.) https://dx.doi.org/10.18565/aig.2018.10.136-140
6. Shang WQ, Yu JJ, Zhu L, Zhou WJ, Chang KK, et al. Blocking of IL-22, a potential strategy for the treatment of adenomyosis by inhibiting crosstalk between the vasoendothelial and endometrial stromal cells. Am. J. Transl. Res. 2015;7(10):178297. PMID: 26692924
7. Tapmeier TT, Becker MK. A pale way to understand adenomyosis? Fertility and Sterility. 2015;104(6):1378. https:// dx.doi.org/10.1016/j.fertnstert.2015.10.005
8. Benadiano G, Brosens I, Habib M. Adenomyosis: the approach from the point of view of the life cycle. Reproductive BioMedicine Online. 2015;30(3):220-32. https://dx.doi. org/10.1016/j.rbmo.2014.11.005
9. Berlac JF, Hartwell D, Skovlund CW, Langhoff-Roos J, Lidegaard. Endometriosis increases the risk of obstetric and neonatal complications. ActaObstetGynecolScand. 2017;96(6):751-760. https://dx.doi.org/10.1111/aogs.13111
10. Salim R, Riris S, Saab W, Abramov B, Khadum I, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF. ReprodBioMed Online. 2012;25(3):273-277. https:// dx.doi.org/10.1016/j.rbmo.2012.05.003.
11. Hamdan M, Omar SZ, Dunselman G, Cheong Y. Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet. Gynecol. 2015;125(1):79-88. https://dx.doi.org/10.1097/ AOG.0000000000000592
12. Breusenko V.G., Kappusheva L.M., Mishieva O.I., Kirikova Yu.M., Tsechoeva T.S., et al. Endoscopic criteria for adenomyosis. Abstracts of the Congress report (Endoscopy in the diagnosis and treatment of uterine pathology). Moscow, 1997. (in Russ.)
13. Mogilnaya G.M., Kutsenko I.I., Simovonik A.N. Morphometric characteristic of nuclear junction zone myometrium cells in adenomyosis. Kuban Scientific Medical Bulletin. 2016;(3):88-91. (In Russ.) https://doi.org/10.25207/16086228-2016-3-88-91
Review
For citations:
Kravtsova E.I., Kutsenko I.I., Avakimyan A.A. FEATURES OF THE COURSE OF PREGNANCY, CHILDBIRTH AND POSTPARTUM PERIOD IN PATIENTS WITH ADENOMYOSIS. Medical Herald of the South of Russia. 2020;11(1):41-45. (In Russ.) https://doi.org/10.21886/2219-8075-2020-11-1-41-45
Views:
7106
Email this article 